Jason Y. Chang is currently the Chief Executive Officer and Chairman of CSBio. CSBio is a life science company focused on clinical and commercial drug substance manufacturing in the Bay Area for new therapeutic peptides.
Chang has 10+ years of experience as a senior executive and has played an integral role in the growth of CSBio. He oversees key company initiatives in both science and new business verticals. In 2017, FDA qualified CSBio’s cGMP facility for commercial production. In order to better serve personalized oncology clinical trials and the greater life science industry, Chang is focused on expanding to a second cGMP facility in Milpitas and receiving entitlements to develop a life science incubator in Menlo Park.
Chang has a passion for cars and motorcycles and is often found at the racetrack. He is also a Board Member of the Rector’s Council at Lincoln College (University of Oxford).
A native of the Bay Area, Chang earned his Bachelor of Arts Economics degree at the University of California, San Diego in 2002 and his Master in Biochemistry degree from the University of Oxford in 2009.